«Paranoid

Below is an extended Paranoid patents listing. Click here to return to the Paranoid main in depth entry.

Patents :
US Patent No.	Title
7244843	Modulators of serotonin receptors
7276631	Cyclopentylamine and cyclohexylamine derivatives as NK-1/SSRI antagonists
7277941	System and method for providing encryption in a storage network by storing a secured encryption key with encrypted archive data in an archive storage device
7279493	Therapeutic agents useful for treating pain
7281020	Proprietary information identification, management and protection
7302566	Internet security system
7305624	Method for limiting Internet access
7309702	Arylpiperazines having activity at the serotonin 1.sub.A receptor
7313442	Method of treating mood disorders and/or anxiety disorders by brain stimulation
7314882	Bicyclic heterocycles as cannabinoid receptor modulators
7317012	Bicyclic heterocycles as cannabinoind-1 receptor modulators
7276608	Tetrahydroquinoline derivatives as cannabinoid receptor modulators
7276593	Proteins and nucleic acids encoding same
7253166	6-phenyl-7H-pyrrolo[2,3-d]pyrimidine compounds that induce neuronal differentiation in embryonic stem cells
7253284	Chemical compounds
7256193	Therapeutic agents useful for treating pain
7262194	Therapeutic agents useful for treating pain
7265103	Substituted amino isoxazoline derivatives and their use as anti-depressants
7268142	Tetrahydroisoquinolinyl derivatives of quinazoline and isoquinoline
7271243	Full-length human cDNAs encoding potentially secreted proteins
7271266	Substituted 2,3-diphenyl pyridines
7273871	Phenyl-5,6,6A,7,8,9-hexahydro-4H-1,4,9-triaza-phenalene derivatives as CRF antagonists
7276509	Piperidine derivatives and their use as antagonists of tachykinins
7326706	Pyrazine modulators of cannabinoid receptors
7332606	Process for producing 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine or hydrochloride thereof
7378492	CD40-related receptor that binds CD40L
7378496	hKCa3/KCNN3 small conductance calcium activated potassium channel: a diagnostic marker and therapeutic target
7384934	Piperazine substituted aryl benzodiazepines
7390835	Aralkyl amines as cannabinoid receptor modulators
7395201	System and method for computer analysis of computer generated communications to produce indications and warning of dangerous behavior
7396663	Isolated polynucleotide encoding a G-protein coupled receptor
7396857	Therapeutic combinations for the treatment or prevention of depression
7402687	Dihydrobenzofuran derivatives and uses thereof
7405221	Substituted pyrimidines
7410759	Compositions and methods for diagnosing and treating mood disorders
7378418	Azabicyclic heterocycles as cannabinoid receptor modulators
7368477	Benzofuranyl alkanamine derivatives and uses thereof
7335640	Administration of hypocretin-1 for treatment of narcolepsy
7341832	Genes involved in neuropsychiatric disorders
7341844	Methods for diagnosing autism
7342017	1,2,5-Thiadiazol-3-yl-piperazine therapeutic agents useful for treating pain, depression and anxiety
7345038	Pyridyloxymethyl and benzisoxazole azabicyclic derivatives
7348456	Substituted amides
7361766	Bicyclic heterocycles as cannabinoid receptor modulators
7365095	Chromane and chromene derivatives and uses thereof
7368270	Human phospholipases
7368458	Bicyclic heterocycles as cannabinoid receptor modulators
7410970	Substituted 1,4,-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.